Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Healthy women tend to lose more hair in July and April, and the least in February.